These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31918124)

  • 1. Spontaneous K-Complexes may be biomarkers of the progression of amnestic mild cognitive impairment.
    Liu S; Pan J; Lei Q; He L; Zhong B; Meng Y; Li Z
    Sleep Med; 2020 Mar; 67():99-109. PubMed ID: 31918124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-antichymotrypsin may be a biomarker for the progression of amnestic mild cognitive impairment.
    Liu S; Pan J; Tang K; Lei Q; He L; Cai X; Li Z
    Acta Neurol Belg; 2021 Apr; 121(2):451-464. PubMed ID: 31494860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer's disease.
    Liu S; Pan J; Tang K; Lei Q; He L; Meng Y; Cai X; Li Z
    Sleep Breath; 2020 Jun; 24(2):637-651. PubMed ID: 31786748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled sevoflurane may promote progression of amnestic mild cognitive impairment: a prospective, randomized parallel-group study.
    Liu Y; Pan N; Ma Y; Zhang S; Guo W; Li H; Zhou J; Liu G; Gao M
    Am J Med Sci; 2013 May; 345(5):355-60. PubMed ID: 23044653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and neuroimaging characteristics of amnestic mild cognitive impairment subtypes: a selective overview.
    Li X; Zhang ZJ
    CNS Neurosci Ther; 2015 Oct; 21(10):776-83. PubMed ID: 25809732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hard Test Your Memory. Evaluation of a short cognitive test to detect mild Alzheimer's disease and amnestic mild cognitive impairment.
    Brown JM; Wiggins J; Dong H; Harvey R; Richardson F; Hunter K; Dawson K; Parker RA
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):272-80. PubMed ID: 23929807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    Li W; Zhao Z; Liu M; Yan S; An Y; Qiao L; Wang G; Qi Z; Lu J
    J Alzheimers Dis; 2022; 85(3):1063-1075. PubMed ID: 34897092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    Wang T; Zhang W; Maclin JMA; Xu H; Hong B; Yan F; Liu Y; He H; Liang H; Li C; Fang Y; Xiao S
    J Alzheimers Dis; 2024; 99(4):1385-1396. PubMed ID: 38788072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    Chen Y; Lin C; Guo Z; Zhao S; Zhu Y; Huang F; Shui G; Lam SM; Pu J; Yan Y; Liu Z; Zhang B
    J Alzheimers Dis; 2020; 73(2):811-818. PubMed ID: 31868671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging.
    Li J; Broster LS; Jicha GA; Munro NB; Schmitt FA; Abner E; Kryscio R; Smith CD; Jiang Y
    Alzheimers Res Ther; 2017 Jan; 9(1):3. PubMed ID: 28100252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech silence character as a diagnostic biomarker of early cognitive decline and its functional mechanism: a multicenter cross-sectional cohort study.
    Wang HL; Tang R; Ren RJ; Dammer EB; Guo QH; Peng GP; Cui HL; Zhang YM; Wang JT; Xie XY; Huang Q; Li JP; Yan FH; Chen SD; He NY; Wang G
    BMC Med; 2022 Nov; 20(1):380. PubMed ID: 36336678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer's disease.
    Agostini S; Mancuso R; Baglio F; Cabinio M; Hernis A; Costa AS; Calabrese E; Nemni R; Clerici M
    Brain Behav Immun; 2016 Nov; 58():254-260. PubMed ID: 27470229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.